Sanofi Reports Positive Late-Stage Results for New Respiratory Vaccine
French pharmaceutical company Sanofi has reported promising phase-three trial results for a next-generation respiratory vaccine, strengthening the prospects for a new product ahead of the winter respiratory infection season.